Loading
institutionsInstitution
Rambam Health Care Campus
Northern Israel's tertiary hospital, affiliated with the Technion, where the ubiquitin-proteasome discoveries behind proteasome inhibitors and degraders were made.
Also called: Rambam Medical CenterRambam Hospital
Overview
Rambam Health Care Campus is the largest hospital in northern Israel and the teaching hospital of the Technion's Rappaport Faculty of Medicine, where Aaron Ciechanover and Avram Hershko carried out the Nobel-recognised work on ubiquitin-mediated protein degradation that underlies bortezomib and targeted protein degraders. Its Joseph Fishman Oncology Center provides medical, radiation and surgical oncology, haematology and transplantation, and paediatric haemato-oncology for a diverse population; Irit Ben-Aharon leads gastrointestinal oncology with a research focus on early-onset colorectal cancer. Rambam participates in Israeli cooperative and international trials and hosts translational research in cancer metabolism and immunology.
Location
Haifa, IL
Type
hospital · Technion, Israel Institute of Technology
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#278 · 24 points (0 Newsweek + 0 NCI + 24 from 12 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-16.
Matched to Rambam Health Care Campus, including child institutions. 294 works · 1,908 citations · 68% open access · 15% clinical trials · 1% reviews.
Oncology works per year
462022
592023
732024
662025
502026
Most works
- Ofrat Beyar‐Katz38 works
- Tsila Zuckerman27 works
- Ruth Perets26 works
- Roni Shouval24 works
- Ronit Marcus21 works
- Alona Zer20 works
- Miguel‐Angel Perales18 works
- Gilles Salles17 works
- Efrat Luttwak16 works
- Gunjan L. Shah16 works
Most cited
- Joseph Fishman Oncology Center
- Ubiquitin-proteasome heritage (Technion)
- Gastrointestinal oncology
- Haematology and transplantation
Aaron Ciechanover
Distinguished Research Professor, Rappaport-Technion Integrated Cancer Center and Rappaport Faculty of Medicine, Technion
Ubiquitin-proteasome systemProtein degradationTargeted protein degradation
Shared the 2004 Nobel Prize in Chemistry for discovering how cells label proteins for destruction. That labelling system is what proteasome inhibitors block and what every protein degrader hijacks.
Michal Mekel
Director General of Rambam Health Care Campus
Endocrine surgeryHospital managementSurgical oncology
Endocrine surgeon who leads Rambam Health Care Campus, the largest hospital in northern Israel, after nearly three decades at the institution.
Similar pages
- PersonAvram Hershko
Shares Technion, Israel Institute of Technology, PROTACs & molecular glues (targeted protein degradation).
- PersonMoshe Oren
Shares Weizmann Institute of Science, PROTACs & molecular glues (targeted protein degradation).
- InstitutionRamathibodi Hospital, Mahidol University
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionHamad Medical Corporation / National Center for Cancer Care and Research
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
- TechnologyMolecular glue discovery platforms
Shares Aaron Ciechanover, Technion, Israel Institute of Technology, PROTACs & molecular glues (targeted protein degradation).
- InstitutionTawam Hospital
Shares Allogeneic (off-the-shelf) cell therapy, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer, Colorectal cancer.
- InstitutionTata Medical Center, Kolkata
Shares Allogeneic (off-the-shelf) cell therapy, Acute myeloid leukaemia, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer.
- InstitutionTel Aviv Sourasky Medical Center
Shares Sheba Medical Center, IMRT / IGRT (modern external beam), HR-positive / HER2-negative breast cancer, Colorectal cancer.